Pure Global

Roche Vantana Silver in Situ Hybridization BF Detection Reagent (Non-Sterile) - Taiwan Registration 55bda4daba7f09b660adc7f834e77bd3

Access comprehensive regulatory information for Roche Vantana Silver in Situ Hybridization BF Detection Reagent (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 55bda4daba7f09b660adc7f834e77bd3 and manufactured by VENTANA MEDICAL SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
55bda4daba7f09b660adc7f834e77bd3
Registration Details
Taiwan FDA Registration: 55bda4daba7f09b660adc7f834e77bd3
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Roche Vantana Silver in Situ Hybridization BF Detection Reagent (Non-Sterile)
TW: "็พ…ๆฐ" ๅ‡กๅก”้‚ฃ้Š€่‰ฒๅŽŸไฝ้›œไบค BF ๅตๆธฌ่ฉฆๅŠ‘(ๆœชๆป…่Œ)
Risk Class 1

Registration Details

55bda4daba7f09b660adc7f834e77bd3

DHA09402361103

Company Information

United States

Product Details

It is limited to the first level of identification scope of the "Immunopathological Histochemical Reagents and Sets (B.1860)" for the classification and grading management measures of medical devices.

B Hematology, pathology, and genetics

B.1860 Immunopathological histochemistry reagents and kits

Input;; QMS/QSD

Dates and Status

Sep 23, 2024

Sep 23, 2029